| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 心胸外科类(元) | 73,436,532.34 | 34,980,250.73 | 72,571,479.18 | 34,722,350.40 |
| 血液净化类(元) | 1,360,561,291.29 | 625,591,593.52 | 1,217,009,306.11 | 522,505,539.02 |
| 注射类(元) | 170,078,114.71 | 82,409,828.82 | 189,798,244.59 | 97,025,475.59 |
| 其他类(元) | 36,119,934.11 | 17,826,294.71 | 21,059,387.86 | 32,199,228.91 |
| 营业成本(元) | ||||
| 心胸外科类(元) | 24,764,623.79 | 12,559,847.52 | 27,127,380.13 | 12,582,540.39 |
| 血液净化类(元) | 880,767,963.14 | 411,007,718.32 | 803,006,502.30 | 345,447,768.29 |
| 注射类(元) | 121,629,886.89 | 60,036,461.59 | 127,277,453.52 | 65,727,219.83 |
| 其他类(元) | 22,171,972.68 | 11,127,962.47 | 12,927,004.06 | 21,800,387.53 |
| 毛利(元) | ||||
| 心胸外科类(元) | 48,671,908.55 | 22,420,403.21 | 45,444,099.05 | 22,139,810.01 |
| 血液净化类(元) | 479,793,328.15 | 214,583,875.20 | 414,002,803.81 | 177,057,770.73 |
| 注射类(元) | 48,448,227.82 | 22,373,367.23 | 62,520,791.07 | 31,298,255.76 |
| 其他类(元) | 13,947,961.43 | 6,698,332.24 | 8,132,383.80 | 10,398,841.38 |
| 毛利率(%) | ||||
| 心胸外科类(%) | 66.28 | 64.09 | 62.62 | 63.76 |
| 血液净化类(%) | 35.26 | 34.30 | 34.02 | 33.89 |
| 注射类(%) | 28.49 | 27.15 | 32.94 | 32.26 |
| 其他类(%) | 38.62 | 37.58 | 38.62 | 32.30 |
| 收入构成(%) | ||||
| 心胸外科类(%) | 4.48 | 4.60 | 4.84 | 5.06 |
| 血液净化类(%) | 82.95 | 82.23 | 81.11 | 76.12 |
| 注射类(%) | 10.37 | 10.83 | 12.65 | 14.13 |
| 其他类(%) | 2.20 | 2.34 | 1.40 | 4.69 |
| 毛利构成(%) | ||||
| 心胸外科类(%) | 8.24 | 8.43 | 8.57 | 9.19 |
| 血液净化类(%) | 81.20 | 80.65 | 78.10 | 73.50 |
| 注射类(%) | 8.20 | 8.41 | 11.79 | 12.99 |
| 其他类(%) | 2.36 | 2.52 | 1.53 | 4.32 |